Boryung Pharmaceutical Co., Ltd
Clinical trials sponsored by Boryung Pharmaceutical Co., Ltd, explained in plain language.
-
Researchers test gentler dosing for schizophrenia medication
Disease control Recruiting nowThis study is testing two different schedules for starting the antipsychotic medication olanzapine in people with schizophrenia. It aims to find out which schedule is safer and works better at controlling symptoms. The trial will involve 120 participants and carefully measure bot…
Phase: PHASE2 • Sponsor: Boryung Pharmaceutical Co., Ltd • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC
-
Real-World check on promising lung cancer drug
Disease control Recruiting nowThis study aims to see how well the drug Zepzelca works and how safe it is for patients with advanced small cell lung cancer in everyday medical practice. It will observe about 300 patients whose cancer has spread and who have already tried standard chemotherapy. The main goal is…
Sponsor: Boryung Pharmaceutical Co., Ltd • Aim: Disease control
Last updated Mar 30, 2026 14:32 UTC
-
Diabetes drug switch tested for better blood sugar control
Disease control Recruiting nowThis study is testing whether switching one medication in a three-drug combination works better for controlling type 2 diabetes. Researchers are comparing two different medication combinations in adults with type 2 diabetes to see which one manages blood sugar more effectively ov…
Phase: PHASE4 • Sponsor: Boryung Pharmaceutical Co., Ltd • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC
-
Massive 20,000-Person study tests blood pressure pill safety
Disease control Recruiting nowThis study is observing how well two different combination pills work to control high blood pressure and what side effects patients experience. It will follow 20,000 adults with high blood pressure for up to 2 years in their regular doctor's offices. The goal is to gather real-wo…
Sponsor: Boryung Pharmaceutical Co., Ltd • Aim: Disease control
Last updated Mar 23, 2026 15:29 UTC
-
Massive 9,000-Person study tracks Real-World results for common diabetes drug
Disease control Recruiting nowThis study is observing how well the medication dapagliflozin works for people who have both type 2 diabetes and high blood pressure. It will follow 9,000 patients in real-world settings to see how effectively it controls their blood sugar and blood pressure, and to monitor for a…
Sponsor: Boryung Pharmaceutical Co., Ltd • Aim: Disease control
Last updated Mar 23, 2026 15:19 UTC
-
Massive study tests new combo pill to tame cholesterol
Disease control Recruiting nowThis study is testing a single pill that combines two cholesterol-lowering medicines (pitavastatin and ezetimibe) in a real-world setting. It aims to see how well and safely this combination helps over 8,600 people with high cholesterol reach their target 'bad' cholesterol levels…
Sponsor: Boryung Pharmaceutical Co., Ltd • Aim: Disease control
Last updated Mar 18, 2026 14:41 UTC
-
Massive study launches to track Real-World bipolar treatment
Knowledge-focused Recruiting nowThis study aims to observe and understand how olanzapine is used to treat bipolar disorder in real-world settings. It will follow 3,000 patients to see what other treatments they receive and if providing education about weight gain, a common side effect, helps prevent it. The goa…
Sponsor: Boryung Pharmaceutical Co., Ltd • Aim: Knowledge-focused
Last updated Mar 25, 2026 14:07 UTC
-
Tracking the next steps: what happens when first cancer treatment fails?
Knowledge-focused Recruiting nowThis study aims to understand what treatment options doctors choose for patients with advanced colorectal cancer after their initial chemotherapy stops working. It will follow 1,000 patients to see which subsequent treatment approaches are most common and how well patients do wit…
Sponsor: Boryung Pharmaceutical Co., Ltd • Aim: Knowledge-focused
Last updated Mar 19, 2026 14:55 UTC
-
Tracking Alcohol's hidden effects in breast cancer treatment
Knowledge-focused Recruiting nowThis study aims to understand what symptoms breast cancer patients experience that may be linked to the alcohol content in a specific chemotherapy drug. Researchers will observe over 1,000 patients receiving this drug either before or after surgery. The goal is to gather informat…
Sponsor: Boryung Pharmaceutical Co., Ltd • Aim: Knowledge-focused
Last updated Mar 09, 2026 14:25 UTC